Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Daily News

Site Investigators Missed Clinical Events in GLOBAL LEADERS

Michael O'Riordan

February 12, 2021

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Yael L. Maxwell

October 16, 2019

News Daily News

ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes

Todd Neale

August 17, 2018

News Daily News

Efficiency Improvements Increase Cath Lab Use as Well as Employee Satisfaction

Yael L. Maxwell

February 02, 2018

News Daily News

ZEUS发布：在“不确定”DES候选者中，带个性化DAPT的ZES胜过裸金属支架

L.A. McKeown

February 25, 2015

News Daily News

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

L.A. McKeown

February 25, 2015

News Daily News

ZEUS Publicado: Los SLZ + Tratamiento Antiplaquetario Doble Personalizado Superan a los SMD en Candidatos SLF ‘Inciertos’

L.A. McKeown

February 25, 2015

News Daily News

Clinical Variables Added to Syntax Score Increases Predictive Ability

L.A. McKeown

September 30, 2011

Advertisement

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Site Investigators Missed Clinical Events in GLOBAL LEADERS

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes

Efficiency Improvements Increase Cath Lab Use as Well as Employee Satisfaction

ZEUS发布：在“不确定”DES候选者中，带个性化DAPT的ZES胜过裸金属支架

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

ZEUS Publicado: Los SLZ + Tratamiento Antiplaquetario Doble Personalizado Superan a los SMD en Candidatos SLF ‘Inciertos’

Clinical Variables Added to Syntax Score Increases Predictive Ability

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content